Eyewire Today

Advertisement

Archives: Acquisitions/Mergers

Show articles per page

Monday, July 28, 2014

Alphaeon Acquires PRN Specialty Nutriceutical Company

From Alphaeon Corp.

Alphaeon Corp., a subsidiary of Strathspey Crown Holdings LLC, announced that it has acquired Physician Recommended Nutriceuticals (PRN) of Plymouth Meeting, Pennsylvania, a developer of specialty ome... Read full article

Friday, July 18, 2014

AbbVie Is Biggest to Quit U.S. Address in $55 Billion Shire Deal

From Bloomberg

AbbVie Inc. agreed to buy Shire Plc for 32 billion pounds ($54.8 billion), becoming the largest U.S. company to ever take a foreign address to lower its taxes. Shire holders will receive cash and stock valued at 52.48 po... Read full article

Thursday, July 17, 2014

NanoVision Group and OVI Lens Enter Into Advanced Technology Collaboration ...

From NanoVision Group

NanoVision Group and OVI Lens, Italy, have reached an agreement for the manufacturing and distributing of ophthalmic products, and for a collaboration on new technology development, according to a a company news release.... Read full article

Thursday, July 17, 2014

Ackman Urges Allergan to Enter Takeover Negotiations with Valeant

From FirstWord

In a letter to Allergan's board released Wednesday, Pershing Square Capital Management CEO William Ackman criticized directors for their "scorched-earth response" to Valeant Pharmaceuticals' $53.8-billion takeover propos... Read full article

Wednesday, July 09, 2014

Allergan Planning Cost Cuts Amid Valeant Defense

From Bloomberg

Allergan Inc., the Botox maker being pursued by Valeant Pharmaceuticals International Inc. and Bill Ackman's hedge fund, will shelve unpromising pipeline drugs and overhaul management incentives, two people with knowledg... Read full article

Tuesday, July 08, 2014

AbbVie Raises Offer for Shire to $51.5 Billion in Fourth Bid

From Bloomberg

AbbVie Inc. made a fourth offer to buy Shire Plc, raising the price to about 30.1 billion pounds ($51.5 billion) in an effort to bring Shire to the negotiating table. AbbVie increased the offer by about 11 percent to 51.... Read full article

Wednesday, July 02, 2014

Nicox to Acquire Aciex Therapeutics Inc. for Up to $120 Million

From Nicox S.A.

Nicox S.A. announced it has signed an agreement to acquire all of the outstanding equity of Aciex Therapeutics Inc., according to a company news release. The acquisition is aimed to broaden and strengthen Nicoxs therapeu... Read full article

Wednesday, July 02, 2014

Santen Announces Closing of Acquisition of Ophthalmology Assets From Merck

From Santen Inc.

Santen Pharmaceutical announced the closing of an asset purchase agreement which was entered on May 13, 2014 with Merck & Co. with respect to the acquisition of certain ophthalmology assets, following the fulfillment... Read full article

Wednesday, July 02, 2014

Genentech Announces Definitive Agreement to Acquire Seragon Pharmaceuticals

From Genentech

Genentech, the maker of Lucentis (ranibizumab), announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company based in San Diego, according to a company n... Read full article

Tuesday, July 01, 2014

The Cooper Companies Announce Definitive Agreements to Acquire Sauflon Phar...

From The Cooper Companies

The Cooper Companies announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals, a European manufacturer and distributor of soft contact lenses and solutions, in a transaction valued at approx... Read full article

Friday, June 27, 2014

U.S. Senators Seek Review for Hostile Bid on Allergan

From Bloomberg

Seven U.S. senators are asking federal regulators to review the potential impact of a hostile takeover by Valeant of Allergan. Allergan's board has rejected a $54 billion tender offer from Valeant, which is based in Lava... Read full article

Thursday, June 26, 2014

AbbVie Wont Rule Out Going Hostile in Tax-Slashing Deal

From Bloomberg

AbbVie Inc. said its $46.5 billion bid for Shire Plc offers compelling value for Shire shareholders and that it wont rule out going hostile in its drive to acquire the drugmaker. Joining the companies will accelerate sal... Read full article

Monday, June 23, 2014

Akorn Divests ECR Pharmaceuticals to Valeant

From Akorn Inc.

Akorn Inc. announced that it has sold its subsidiary, ECR Pharmaceuticals, to Valeant Pharmaceuticals for $41 million in cash and assumption of certain liabilities. ECR, which promotes certain branded pharmaceuticals thr... Read full article

Thursday, June 19, 2014

Valeant to Take Acquisition Proposal Directly to Shareholders

From Eyewiretoday.com

Valeant announced that it has commenced an exchange offer for the common stock of Allergan, allowing it to take the unsolicited bid directly to Allergan shareholders.We believe Allergans stockholders should have the oppo... Read full article

Tuesday, June 17, 2014

Morgan Stanleys Valeant E-Mails Call Client a 'House of Cards'

From Bloomberg

Put this in the category of, if you cant say something nice, dont write it in an e-mail. A few weeks ago, Morgan Stanley (MS) pitched its defense services to Allergan Inc. (AGN), which was fighting a hostile takeover bid... Read full article

Monday, June 16, 2014

Medtronic to Buy Device Maker Covidien for $42.9 Billion

From Bloomberg

Medtronic Inc., the second-largest maker of medical devices, agreed to buy Covidien Plc (COV) for $42.9 billion in cash and stock as it transforms into a broader-based company bolstered by new tax advantages. Medtronic w... Read full article

Tuesday, June 10, 2014

Allergan Again Unanimously Rejects Valeants Revised Unsolicited Proposal

From Eyewiretoday.com

Allergan has once again rejected the revised unsolicited proposal from Valeant and Pershing Square Capital Management, setting the stage for a lengthy hostile takeover battle. Allergan announced June 10 that its board of... Read full article

Monday, June 09, 2014

Merck to Buy Hepatitis-Drug Maker Idenix

From Bloomberg

Merck & Co. (MRK), the second-biggest U.S. drugmaker, agreed to buy Idenix Pharmaceuticals Inc. (IDIX) for about $3.85 billion to expand its experimental pipeline for hepatitis C treatments. Idenix holders will recei... Read full article

Wednesday, June 04, 2014

Takeover Offer Intensifies as Valeant Again Increases its Bid For Allergan ...

From Eyewiretoday.com

Seeking to increase the pressure on Allergan to negotiate a sale, Valeant and hedge fund manager William Ackman once again announced a series of unconventional moves. In a conference call Monday, Mr. Ackman's Pershing Sq... Read full article

Wednesday, June 04, 2014

Welch Allyn Acquires Assets of PediaVision

From Welch Allyn Inc.

Welch Allyn announced the acquisition of certain assets of PediaVision Holdings LLC, according to a company news release. Founded in 2007, PediaVision of Lake Mary, Florida, is a developer of vision technology and invent... Read full article

Advertisement

Featured Jobs
  • General Ophthalmologist

    , FL (Statewide)

    Established over 60 years ago, one of Floridas busiest and most respected practices is seeking an experience general ophthalmologist. Ideal candidate will have an interest and experience in glaucoma or light plastics as ...